Mod­er­na may be pub­licly piv­ot­ing to­ward its can­cer ther­a­pies, but it's still notch­ing new vac­cine ap­provals along the way. The lat­est reg­u­la­to­ry ap­proval came well af­ter dark on Wednes­day, when the FDA gave the okay to mFLU­SI­VA as a new flu vac­cine op­tion...